Literature DB >> 9809693

Utilization of rheumatology physician services by the elderly.

J N Katz1, J Barrett, M H Liang, H Kaplan, W N Roberts, J A Baron.   

Abstract

PURPOSE: To examine rheumatology subspecialty practice patterns, determinants of referral to rheumatologists, and utilization of aspiration and injection procedures in a population-based sample of elderly individuals. SUBJECTS AND METHODS: We obtained Medicare physician claims for all visits to rheumatologists among beneficiaries aged 65 years and older in Colorado, Massachusetts, and Virginia in 1993, and for visits to all providers by patients with coded diagnoses of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We examined variations in visit frequency and aspiration/injection procedures, and we analyzed determinants of referral to a rheumatologist for RA or SLE.
RESULTS: In 1 year, 144,797 visits were made to rheumatologists by 38,443 patients in the three states. An inflammatory disorder was coded in 45% of visits and a noninflammatory disorder in 50%. Half of patients with RA were seen three or fewer times in the year. For RA and SLE, African Americans were about 60% as likely to be seen by a rheumatologist as whites. Utilization of rheumatologist services for rheumatoid arthritis and systemic lupus erythematosus was highest in the state (Virginia) with the lowest per capita supply of rheumatologists. Among patients with bursitis, tendinitis, and osteoarthritis, African-American women were more likely to receive an injection or aspiration procedure than whites or African-American men.
CONCLUSION: Elderly patients with rheumatologic disorders were seen by specialists less frequently than recommended by a recent rheumatology manpower survey. African-Americans with RA and SLE had fewer rheumatology visits than whites.

Entities:  

Mesh:

Year:  1998        PMID: 9809693     DOI: 10.1016/s0002-9343(98)00273-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus.

Authors:  Chris Tonner; Laura Trupin; Jinoos Yazdany; Lindsey Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

Review 2.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 3.  Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis.

Authors:  Molly D Magnano; Mark C Genovese
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

4.  Development of a structured on-site nursing program for training nurse specialists in rheumatology.

Authors:  Euthalia Roussou; Caroline Iacovou; Louisa Georgiou
Journal:  Rheumatol Int       Date:  2011-03-23       Impact factor: 2.631

5.  Medicaid and access to care among persons with systemic lupus erythematosus.

Authors:  JoAnn Zell Gillis; Jinoos Yazdany; Laura Trupin; Laura Julian; Pantelis Panopalis; Lindsey A Criswell; Patricia Katz; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

6.  Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus.

Authors:  Jinoos Yazdany; JoAnn Zell Gillis; Laura Trupin; Patricia Katz; Pantelis Panopalis; Lindsey A Criswell; Edward Yelin
Journal:  Arthritis Rheum       Date:  2007-05-15

Review 7.  Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus.

Authors:  Shilpa Arora; Jinoos Yazdany
Journal:  Rheum Dis Clin North Am       Date:  2020-09-09       Impact factor: 2.670

8.  Health-related quality of life as a main determinant of access to rheumatologic care.

Authors:  Leticia Leon; Juan Angel Jover; Estibaliz Loza; Maria Victoria Zunzunegui; Cristina Lajas; Cristina Vadillo; Oscar Fontsere; Luis Rodriguez-Rodriguez; Cristina Martinez; Benjamin Fernandez-Gutierrez; Lydia Abasolo
Journal:  Rheumatol Int       Date:  2013-01-11       Impact factor: 2.631

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.